Skip to content

Rosie the Chatbot: Leveraging Automated and Personalized Health Information Communication

Rosie the Chatbot: Leveraging Automated and Personalized Health Information Communication to Reduce Disparities in Maternal and Child Health

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06053515
Enrollment
400
Registered
2023-09-25
Start date
2023-10-13
Completion date
2026-01-23
Last updated
2026-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant Conditions, Infant Development, Postpartum Depression, Pregnancy

Keywords

chatbot, health information, racial/ethnic health disparities, maternal and child health, artificial intelligence, question-answering models

Brief summary

Rosie the Chatbot is an educational chatbot that moms can have on their computers or cellphones and will work by moms typing in their questions about pregnancy, health, infant milestones, and other variety of health related topics and receiving back a response immediately. Rosie only provides information from verified sources such as children's hospitals, health organizations and government agencies. Rosie does not ask moms to provide any personal information on her or her child, her chat is completely confidential, it works in English and Spanish and will be free.

Detailed description

This study will examine whether the use of a chatbot to impart health information to minority women during pregnancy and postpartum period improves health care seeking behavior and maternal and infant health outcomes. This study does not involve administration of an investigational intervention and therefore poses minimal risk to participants. Aim 1: Develop technology for a "chatbot" that will provide health information support to vulnerable mothers the moment they need it. Aim 2: Evaluate the use of Rosie on maternal and infant outcomes. Aim 3: Release an open-source packet for the construction of a chatbot. * Participants in the study will be randomly assigned into one of two groups, Rosie the Chatbot group (treatment group) and Book Club group (control group). * Participants in the Rosie the Chatbot Group will be taking a pre-test health survey, mid-test health survey, and post-test health survey. In addition, they will be expected to actively use the chatbot app by asking questions related to maternal and infant health and selecting "thumbs up or thumbs down" to provide feedback for questions' response and use the features (video library, resources page, frequently asked questions (FAQ), and daily syllabus). * Participants in the Book Club Group will be taking a pre-test health survey, mid-test health survey, and post-test health survey. In addition, they will receive a monthly children's book, which they are expected to read with baby if parenting or individually if pregnant.

Interventions

BEHAVIORALRosie the Chatbot

Participants in the intervention group will be using the chatbot to ask questions related to the mom and baby's health, provide feedback "selecting thumbs up or thumbs down" on the questions' response, and use the features (video library, resources page, frequently asked questions (FAQ), and daily syllabus). In addition, participants will be taking a pre-test health survey, mid-test health survey, and post-test health survey.

Sponsors

University of Maryland, College Park
Lead SponsorOTHER
National Institutes of Health (NIH)
CollaboratorNIH
National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
14 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 14 years and older * Racial minority women * Pregnant or has an infant \< 6 months * Must be able to read English or Spanish

Exclusion criteria

* Mother younger than 14 years of age at time of child's birth. * Non-hispanic white

Design outcomes

Primary

MeasureTime frameDescription
Maternal postpartum depression12 months post randomizationThe investigators will utilize the Patient Health Questionnaire (PHQ-9) Scale to measure maternal depression. This scale can range from 0 to 27, since each of the 9 items can be scored from 0 (not at all) to 3 (nearly every day). Higher scores indicate worse depression severity.
Number of emergency room visits12 months post randomizationThe investigators will measure the number of visits to the emergency room.
Attendance of well-baby visits (preventive healthcare visits)12 months post randomizationThe investigators will measure the number of well-baby visits.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORQuynh C Nguyen, PhD

University of Maryland

PRINCIPAL_INVESTIGATORElizabeth M Aparicio, PhD, LCSW-C

University of Maryland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 6, 2026